Antiva Biosciences' Series A Round

Antiva Biosciences raised a round of funding on September 05, 2013.

Antiva Biosciences, formerly Hera Therapeutics, is a biopharmaceutical company developing topical therapeutics for the treatment of diseases caused by HPV infection.…

Articles about Antiva Biosciences' Series A Round: